Industry: Pharma & Healthcare
Published Date: 2025-01-16
Pages: 68 Pages
Report ld: 3466441
Request Sample
Customized Report
The global market for Mildronate Dihydrate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
In Europe, Mildronate Dihydrate key players include Grindeks, etc. Global top one manufacturers hold a share over 99%.
Russia is the largest market, with a share about 40%, followed by Latvia, and Lithuania, both have a share over 5 percent.
In terms of product, Capsule is the largest segment, with a share over 55%. And in terms of application, the largest application is Cardiovascular Disease, etc.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Mildronate Dihydrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mildronate Dihydrate.
The Mildronate Dihydrate market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Mildronate Dihydrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mildronate Dihydrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Grindeks
Segment by Type
Capsule
Injection
Tablet
Segment by Application
Cardiovascular Disease
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Mildronate Dihydrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Mildronate Dihydrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Mildronate Dihydrate Market Overview
1.1 Product Definition
1.2 Mildronate Dihydrate by Type
1.2.1 Global Mildronate Dihydrate Market Value Comparison by Type (2024 VS 2031)
1.2.2 Capsule
1.2.3 Injection
1.2.4 Tablet
1.3 Mildronate Dihydrate by Application
1.3.1 Global Mildronate Dihydrate Market Value by Application (2024 VS 2031)
1.3.2 Cardiovascular Disease
1.3.3 Others
1.4 Global Mildronate Dihydrate Market Size Estimates and Forecasts
1.4.1 Global Mildronate Dihydrate Revenue 2020-2031
1.4.2 Global Mildronate Dihydrate Sales 2020-2031
1.4.3 Global Mildronate Dihydrate Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Mildronate Dihydrate Market Competition by Manufacturers
2.1 Global Mildronate Dihydrate Sales Market Share by Manufacturers (2020-2025)
2.2 Global Mildronate Dihydrate Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Mildronate Dihydrate Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Mildronate Dihydrate, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mildronate Dihydrate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mildronate Dihydrate, Product Type & Application
2.7 Global Key Manufacturers of Mildronate Dihydrate, Date of Enter into This Industry
2.8 Global Mildronate Dihydrate Market Competitive Situation and Trends
2.8.1 Global Mildronate Dihydrate Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mildronate Dihydrate Players Market Share by Revenue
2.8.3 Global Mildronate Dihydrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mildronate Dihydrate Market Scenario by Region
3.1 Global Mildronate Dihydrate Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Mildronate Dihydrate Sales by Region: 2020-2031
3.2.1 Global Mildronate Dihydrate Sales by Region: 2020-2025
3.2.2 Global Mildronate Dihydrate Sales by Region: 2026-2031
3.3 Global Mildronate Dihydrate Revenue by Region: 2020-2031
3.3.1 Global Mildronate Dihydrate Revenue by Region: 2020-2025
3.3.2 Global Mildronate Dihydrate Revenue by Region: 2026-2031
3.4 North America Mildronate Dihydrate Market Facts & Figures by Country
3.4.1 North America Mildronate Dihydrate Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Mildronate Dihydrate Sales by Country (2020-2031)
3.4.3 North America Mildronate Dihydrate Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Mildronate Dihydrate Market Facts & Figures by Country
3.5.1 Europe Mildronate Dihydrate Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Mildronate Dihydrate Sales by Country (2020-2031)
3.5.3 Europe Mildronate Dihydrate Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mildronate Dihydrate Market Facts & Figures by Region
3.6.1 Asia Pacific Mildronate Dihydrate Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Mildronate Dihydrate Sales by Region (2020-2031)
3.6.3 Asia Pacific Mildronate Dihydrate Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Mildronate Dihydrate Market Facts & Figures by Country
3.7.1 Latin America Mildronate Dihydrate Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Mildronate Dihydrate Sales by Country (2020-2031)
3.7.3 Latin America Mildronate Dihydrate Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Mildronate Dihydrate Market Facts & Figures by Country
3.8.1 Middle East and Africa Mildronate Dihydrate Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Mildronate Dihydrate Sales by Country (2020-2031)
3.8.3 Middle East and Africa Mildronate Dihydrate Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mildronate Dihydrate Sales by Type (2020-2031)
4.1.1 Global Mildronate Dihydrate Sales by Type (2020-2025)
4.1.2 Global Mildronate Dihydrate Sales by Type (2026-2031)
4.1.3 Global Mildronate Dihydrate Sales Market Share by Type (2020-2031)
4.2 Global Mildronate Dihydrate Revenue by Type (2020-2031)
4.2.1 Global Mildronate Dihydrate Revenue by Type (2020-2025)
4.2.2 Global Mildronate Dihydrate Revenue by Type (2026-2031)
4.2.3 Global Mildronate Dihydrate Revenue Market Share by Type (2020-2031)
4.3 Global Mildronate Dihydrate Price by Type (2020-2031)
5 Segment by Application
5.1 Global Mildronate Dihydrate Sales by Application (2020-2031)
5.1.1 Global Mildronate Dihydrate Sales by Application (2020-2025)
5.1.2 Global Mildronate Dihydrate Sales by Application (2026-2031)
5.1.3 Global Mildronate Dihydrate Sales Market Share by Application (2020-2031)
5.2 Global Mildronate Dihydrate Revenue by Application (2020-2031)
5.2.1 Global Mildronate Dihydrate Revenue by Application (2020-2025)
5.2.2 Global Mildronate Dihydrate Revenue by Application (2026-2031)
5.2.3 Global Mildronate Dihydrate Revenue Market Share by Application (2020-2031)
5.3 Global Mildronate Dihydrate Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Grindeks
6.1.1 Grindeks Company Information
6.1.2 Grindeks Description and Business Overview
6.1.3 Grindeks Mildronate Dihydrate Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Grindeks Mildronate Dihydrate Product Portfolio
6.1.5 Grindeks Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mildronate Dihydrate Industry Chain Analysis
7.2 Mildronate Dihydrate Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mildronate Dihydrate Production Mode & Process Analysis
7.4 Mildronate Dihydrate Sales and Marketing
7.4.1 Mildronate Dihydrate Sales Channels
7.4.2 Mildronate Dihydrate Distributors
7.5 Mildronate Dihydrate Customer Analysis
8 Mildronate Dihydrate Market Dynamics
8.1 Mildronate Dihydrate Industry Trends
8.2 Mildronate Dihydrate Market Drivers
8.3 Mildronate Dihydrate Market Challenges
8.4 Mildronate Dihydrate Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 71
USD 4250.00
(Single User License)
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 95
USD 2900.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-04
Pages: 85
USD 3950.00
(Single User License)
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 122
USD 4900.00
(Single User License)
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 116
USD 5900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 67
USD 4250.00
(Single User License)
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 90
USD 3950.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-17
Pages: 122
USD 5600.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-16
Pages: 121
USD 5900.00
(Single User License)
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published Date: 2024-04-07
Pages: 71
USD 4900.00
(Single User License)
The global Mildronate Dihydrate market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 71
The global Mildronate Dihydrate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 95
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-04
Pages: 85
The global Mildronate Dihydrate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 122
In 2024, the global market size of Mildronate Dihydrate was estimated to be worth US$ million and is forecast to reach approximately US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 116
The global Mildronate Dihydrate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 67
The global market for Mildronate Dihydrate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 90
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-17
Pages: 122
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-16
Pages: 121
Mildronate is a registered trademark of the Grindex. Its active substance is meldonium. Meldonium is a limited-market pharmaceutical, and is an ‘anti-ischemic’ drug, which means it is used to treat inadequate blood-flow to the organs, especially the heart. It is primarily used to treat patients with heart conditions that affect the body’s ability to deliver oxygen to the body. It helps to protect against tissue damage from angina attacks, chronic heart failure and disorders of brain circulation.
Published: 2024-04-07
Pages: 71
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now